“We’ll become a company leading the obesity market within 10 years”
The obesity rate has finally exceeded 37% for adults over 30 in Korea, which means 1 of 3 adults are obese. Thus, Novo Nordisk, a global pharmaceutical company, has launched Saxenda(generic name: liraglutide 3.0mg), a glucagon-like peptide 1, for the first time in Asia on the 16th of March.
Appr...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
